Gulcan, H. O. And ERDOĞAN ORHAN, İ. 2020. The Main Targets Involved in Neuroprotection for the Treatment of Alzheimer's Disease and Parkinson Disease. CURRENT PHARMACEUTICAL DESIGN , vol.26, no.4 , 509-516.

Gulcan, H. O., & ERDOĞAN ORHAN, İ., (2020). The Main Targets Involved in Neuroprotection for the Treatment of Alzheimer's Disease and Parkinson Disease. CURRENT PHARMACEUTICAL DESIGN , vol.26, no.4, 509-516.

Gulcan, Hayrettin, And İLKAY ERDOĞAN ORHAN. "The Main Targets Involved in Neuroprotection for the Treatment of Alzheimer's Disease and Parkinson Disease," CURRENT PHARMACEUTICAL DESIGN , vol.26, no.4, 509-516, 2020

Gulcan, Hayrettin O. And ERDOĞAN ORHAN, İLKAY E. . "The Main Targets Involved in Neuroprotection for the Treatment of Alzheimer's Disease and Parkinson Disease." CURRENT PHARMACEUTICAL DESIGN , vol.26, no.4, pp.509-516, 2020

Gulcan, H. O. And ERDOĞAN ORHAN, İ. (2020) . "The Main Targets Involved in Neuroprotection for the Treatment of Alzheimer's Disease and Parkinson Disease." CURRENT PHARMACEUTICAL DESIGN , vol.26, no.4, pp.509-516.

@article{article, author={Hayrettin O. Gulcan And author={İLKAY ERDOĞAN ORHAN}, title={The Main Targets Involved in Neuroprotection for the Treatment of Alzheimer's Disease and Parkinson Disease}, journal={CURRENT PHARMACEUTICAL DESIGN}, year=2020, pages={509-516} }